Bioavailability of Etoposide after Oral Administration of the Solution Marketed for Intravenous Use: Therapeutic and Pharmacoeconomic Perspectives
- 30 June 1999
- journal article
- Published by Elsevier in Archives of Medical Research
- Vol. 30 (3) , 212-215
- https://doi.org/10.1016/s0188-0128(99)00014-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Oral Bioavailability of Low Dose (20mg) ‘Home-Made’ Etoposide CapsulesClinical Drug Investigation, 1996
- Therapeutic monitoring of continuous infusion etoposide in small-cell lung cancer.Journal of Clinical Oncology, 1996
- A New Rapid and Economical High Performance Liquid Chromatographic Assay with Electrochemical Detection for the Determination of Etoposide (VP-16) in Human Plasma SamplesJournal of Liquid Chromatography & Related Technologies, 1996
- Pharmacokinetics of Etoposide after Oral and Intravenous Administration in Patients with Gastric CarcinomaClinical Drug Investigation, 1995
- Prolonged administration of low-dose, infusional etoposide in patients with etoposide-sensitive neoplasms: a phase I/II study.Journal of Clinical Oncology, 1993
- EtoposideDrugs, 1990
- Review of methods and criteria for the evaluation of bioequivalence studiesEuropean Journal of Clinical Pharmacology, 1990
- A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.Journal of Clinical Oncology, 1989
- Pharmacokinetics of high dose etoposide (VP 16–213)European Journal of Cancer and Clinical Oncology, 1986
- Etoposide (VP-16–213)New England Journal of Medicine, 1985